Both in Medical Labs
BioNexus Gene Lab vs Castle Biosciences
Over the past year BGLC returned −77.7% and CSTL returned +44.0%; their daily moves had a correlation of 0.06.
BGLC −77.7% CSTL +44.0%Growth of $1, one year, split-adjusted
| Metric | BGLC | CSTL |
|---|---|---|
| Price | $1.13 | $34.51 |
| Market cap | $3.3M | $1.05B |
| Today | −2.59% | +3.63% |
| 1 month | −13.1% | −4.0% |
| 6 months | −45.4% | +39.8% |
| Year to date | −71.4% | −11.3% |
| 1 year | — | +40.8% |
| Revenue growth (YoY) | −96.6% | +20.1% |
| Gross margin | 17.0% | 77.1% |
| Net margin | −376.1% | −2.0% |
| P/E (TTM) | — | — |
| Price / sales | 1.1× | 3.0× |
| Net cash | $1.2M | $256.5M |
| Dividend yield | — | — |
| Volatility (60d) | 65.3% | 48.7% |
| Short % of float | 0.5% | 7.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).